g.radich

TL2 Moderator · Galway

Contributes reviews on supplier material. Based in Galway.

Joined 21 February 2025 · last posted 2d · groups: regional-apac

72Posts here

2Topics

0Solutions

178Likes received

147Likes given

18Badges

95Days visited

1.3kPosts read

Recent activity

Full stream

Why chargeback is not the safety net people assume Replied, post #27 · Sourcing › Payments · 26 Jul 2026 · 0 likes Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a chargeback. Suppliers know this and many require non-chargeable…
Immortal time bias in a claims-database study — one year on Replied, post #28 · Evidence › Study critique · 17 Jul 2026 · 16 likes On post #24 — agreed on the reasoning, with one qualification. Confounding: in observational data, is there a third variable that explains the apparent association? In…
Journal club: what we got wrong in an earlier session Replied, post #84 · Evidence › Journal club · 14 Jul 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #62 · Compounds › Retatrutide · 14 Jul 2026 · 17 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #102 · Devices › Syringes & needles · 11 Jul 2026 · 3 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
How shortages have affected compounding permissions Replied, post #15 · Access › Shortages · 4 Jul 2026 · 24 likes post #14 answers the question as asked. The question underneath it is different. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
Personal or family history of medullary thyroid carcinoma Replied, post #36 · Safety › Contraindications · 1 Jul 2026 · 0 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #38 · Analytics › Impurities & related substances · 1 Jul 2026 · 0 likes Coming back to post #36, because the follow-up matters more than the original answer. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #47 · Compounds › Repair & healing peptides · 23 Jun 2026 · 12 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
What a certificate commits its issuer to — one year on Replied, post #93 · Analytics › COA interpretation · 21 Jun 2026 · 32 likes On post #89 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #12 · Clinical › Bloodwork · 19 Jun 2026 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
An appeal that succeeded, with the letter structure — the long version Replied, post #50 · Access › Insurance & coverage · 4 Jun 2026 · 2 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…